HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Resolving Botanicals Deadlock 'Not A Priority' For European Commission

Executive Summary

Tensions between industry and the European Commission on the issue of  health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future. 

You may also be interested in...



AESGP Annual Meeting, Day 2: Communicating Risk, E-Commerce Boom, RWE And Sustainability

Day two of the AESGP's 57th Annual Meeting featured discussions on communicating risk in times of uncertainty, how to foster a harmonized EU market for food supplements and the growth of the ePharmacy channel. The opportunities presented by real-world evidence were also debated, along with the challenges facing the self-care industry in the area of sustainability.

As Botanicals Deadlock Holds Back Investment, Dutch Industry Takes The Initiative

Dutch self-care industry association, Neprofarm, has updated the way it self-regulates botanical health claims in an effort to rebuild confidence in the country's herbal food supplements market. 

EU Health Food Industry Proposes Three-Tier Claims System To Break Botanicals Deadlock

Attempting to find a way out of the current EU botanicals stalemate, the European Health Product Manufacturers Federation (EHPM) outlines a three-level framework for the assessment of health claims made for herbal food supplements.

Related Content

Topics

UsernamePublicRestriction

Register

RS150760

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel